Chai Discovery’s $400m raise triples its value to $3.8bn in seven months. It is the latest sign that AI drug discovery has moved from promise to deployment. AI drug discovery just minted another fast-rising star. Chai Discovery has raised a $400m Series C that values the San Francisco startup at $3.8bn, the company said. That […]<br /> This story continues at The Next Web [...]
Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]
In short: SiFive, the RISC-V chip IP firm founded by the Berkeley engineers who created the open-source instruction set architecture, raised $400 million in an oversubscribed Series G on April 9, 202 [...]
Europe has a new defence-tech heavyweight. Quantum Systems, a German maker of autonomous drones, has raised $1.2bn and more than doubled its valuation to about $8bn. It is one of the largest rounds ev [...]
Isomorphic Labs, the AI drug research company led by DeepMind co-founder Demis Hassabis, has closed a $2.1 billion Series B round led by Thrive Capital. The funding will go toward expanding its in-hou [...]
A bank that barely existed a year ago is now chasing a valuation most European lenders can only dream of. Erebor was founded by Anduril’s Palmer Luckey and backed by Peter Thiel. It is in talks to r [...]
Earlier this summer Engadget covered the news that Warner Bros. Discovery would split into two giant media companies. Today the conglomerate announced the names for the restructured entities.<br /& [...]
Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says doubles AlphaFold 3's accuracy f [...]
Adversaries from cybercrime gangs to nation-state cyberattack squads are fine-tuning weaponized AI with the goal of defeating new patches in 3 days or less. The quicker the attack, the more time to ex [...]